Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi

Amir Kirolos1,2, Todd D Swarthout3,4, Andrew A Mataya3

  • 1Department of Women's and Children's Health, Faculty of Health and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. a.kirolos@liverpool.ac.uk.

BMC Infectious Diseases
|January 26, 2023
PubMed

Insights

Pneumococcal serotypes 5 and 1 show high invasive potential in Malawi children. Understanding serotypes is key for future Streptococcus pneumoniae vaccination strategies.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatrics

Background:

  • The introduction of PCV13 in Malawi has reduced Streptococcus pneumoniae disease.
  • Understanding serotypes with high invasive potential is crucial for future vaccination efforts.

Purpose of the Study:

  • To estimate pneumococcal serotypes associated with acute respiratory infection (ARI) and invasive pneumococcal disease (IPD) in hospitalized children in Blantyre, Malawi.

Main Methods:

  • Analyzed nasopharyngeal swabs from healthy children and hospitalized children with ARI (2015-2018).
  • Serotyped S. pneumoniae using latex agglutination.
  • Analyzed blood and cerebrospinal fluid samples for IPD cases (2012-2018).
  • Calculated odds ratios for serotype carriage and invasive potential.

Main Results:

  • Serotypes 5 and 1 demonstrated high invasive potential (OR > 23, p < 0.001).
  • Community pneumococcal carriage prevalence was 72.6%; 23.4% of positive samples were vaccine types (VT).
  • Carriage prevalence in hospitalized children with ARI was 45.5%; 43.8% reported prior antibiotic use.

Conclusions:

  • Serotypes 5 and 1 are linked to high invasive potential.
  • Pre-hospital antibiotic use may reduce pneumococcal detection in hospitalized children.
  • Further research is needed on ARI-associated serotypes to guide future vaccination strategies in Malawi.
Abstract